search icon
biotw-img

Biotech acquisition company share price

BIOTW
NMQ
$0.059999
+$0
(0%)
1D

Biotech acquisition company analyst forecast

Biotech acquisition company key stock metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$278.30M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
543.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0

About biotech acquisition company, common stock

Biotech Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in New York, New York. more

Biotech acquisition company stock returns

Data is not properly formatted.

Biotech acquisition company financials

Dec '20Dec '21
Total Revenue--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true}]
Cost of Revenue-1.57M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true}]
Gross Profit-(1.57M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-157016500,"profit":false}]
Gross Margin--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true}]
Operating Expenses-1.57M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true}]
Operating Income(5.00K)(1.57M)[{"date":"2020-12-31","value":-500000,"profit":false},{"date":"2021-12-31","value":-157016500,"profit":false}]
Total Non-Operating Income/Expense-(5.27M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-527311300,"profit":false}]
Pre-Tax Income(5.00K)(6.86M)[{"date":"2020-12-31","value":-500000,"profit":false},{"date":"2021-12-31","value":-686458100,"profit":false}]
Income Taxes--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true}]
Income After Taxes--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true}]
Income From Continuous Operations-(6.37M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-636556500,"profit":false}]
Income From Discontinued Operations--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true}]
Net Income(5.00K)(6.86M)[{"date":"2020-12-31","value":-500000,"profit":false},{"date":"2021-12-31","value":-686458100,"profit":false}]
EPS (Diluted)0.09-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true}]

Biotech acquisition company ratios

Biotech acquisition company liquidity ratios

These ratios help you determine the liquidity of the company. Higher is better.

BIOTW
Cash Ratio 0.00
Current Ratio 0.03

Biotech acquisition company asset efficiency ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BIOTW
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Biotech acquisition company liability ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BIOTW
Debt Ratio Lower is generally better. Negative is bad. 0.06
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.94

Biotech acquisition company valuation ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BIOTW
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

Faqs

What is Biotech Acquisition Company share price today?

Biotech Acquisition Company (BIOTW) share price today is $0.059999

Can Indians buy Biotech Acquisition Company shares?

Yes, Indians can buy shares of Biotech Acquisition Company (BIOTW) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BIOTW stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biotech Acquisition Company be purchased?

Yes, you can purchase fractional shares of Biotech Acquisition Company (BIOTW) via the Vested app. You can start investing in Biotech Acquisition Company (BIOTW) with a minimum investment of $1.

How to invest in Biotech Acquisition Company shares from India?

You can invest in shares of Biotech Acquisition Company (BIOTW) via Vested in three simple steps:

  • Click on Sign Up or Invest in BIOTW stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biotech Acquisition Company shares

What is Biotech Acquisition Company 52-week high and low stock price?

The 52-week high price of Biotech Acquisition Company (BIOTW) is $. The 52-week low price of Biotech Acquisition Company (BIOTW) is $.

What is Biotech Acquisition Company price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biotech Acquisition Company (BIOTW) is

What is Biotech Acquisition Company price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biotech Acquisition Company (BIOTW) is 0.00

What is Biotech Acquisition Company dividend yield?

The dividend yield of Biotech Acquisition Company (BIOTW) is 0.00%

What is the Market Cap of Biotech Acquisition Company?

The market capitalization of Biotech Acquisition Company (BIOTW) is $278.30M

What is Biotech Acquisition Company's stock symbol?

The stock symbol (or ticker) of Biotech Acquisition Company is BIOTW

How Can Investors Use Biotech Acquisition Company Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biotech Acquisition Company as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biotech Acquisition Company has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biotech Acquisition Company shares for Indian investors?

When investing in Biotech Acquisition Company shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biotech Acquisition Company stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biotech Acquisition Company share price with other stocks in the same sector?

Rather than merely checking the share price of Biotech Acquisition Company and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biotech Acquisition Company stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top